MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

2023 International Congress

August 27-31, 2023. Copenhagen, Denmark.

View by Title View Categories
Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z
  • Habenula Volume in Mood Disorders in Parkinson’s Disease

    B. Samanci, Y. Temel, M. Kuijf, S. Tan, S. Michielse (Maastricht, Netherlands)

  • Hand to mouth: differences between musicians’ hand and embouchure dystonia

    A. Lee, J. Doll-Lee, E. Altenmüller (Hannover, Germany)

  • Harmonizing genetic testing for early-onset Parkinson’s disease: results of the PARKNET multicentric study

    M. Percetti, E. Monfrini, I. Palmieri, A. Albanese, M. Avenali, A. Bartoletti-Stella, F. Blandini, G. Brescia, G. Calandra-Buonaura, R. Campopiano, S. Capellari, I. Colangelo, G. Comi, G. Cuconato, R. Ferese, C. Galandra, S. Gambardella, B. Garavaglia, A. Gaudio, E. Giardina, F. Invernizzi, P. Mandich, R. Mineri, C. Panteghini, C. Reale, L. Trevisan, S. Zampatti, P. Cortelli, E. Valente, A. Di Fonzo (Milano, Italy)

  • Hazard ratios of suicidality in a large Huntington disease population compared with controls: marginal structural modeling of Enroll-HD registry data

    S. Reshef, V. Sung, G. Smith, O. Harari, D. Zhang, M. Forrest Gordon, R. Willock, R. Ribalov, J. Robles-Zurita, E. Furr Stimming (Parsippany-Troy Hills, USA)

  • Health status of Lewy Body Dementia caregivers predicts psychological response to peer mentoring intervention

    M. Suresh, K. Woo, J. Fleisher (Chicago, USA)

  • Healthcare experiences of People with Parkinson’s Disease (PwP) during COVID-19 pandemic

    V. Tomantschger, A. Tautscher-Basnett, C. Hohenwarter (Hermagor, Austria)

  • Hearing impairment and non-motor symptoms in Parkinson’s disease: association and impact on quality of life

    E. Garasto, M. Conti, A. Viziano, A. Stefani, M. Pierantozzi, NB. Mercuri, A. Moleti, R. Sisto, T. Schirinzi, R. Cerroni (Rome, Italy)

  • Heart-rate variability as a new marker for freezing predisposition in Parkinson’s disease

    B. Heimler, O. Koren, R. Inzelberg, U. Rosenblum, S. Hassin-Baer, G. Zeilig, R. Bartsch, M. Plotnik (Tel Hashomer, Israel)

  • Hemi-dystonia secondary to encephalitis and its response to staged pallidotomy

    S. Yadav, A. Das, A. Srivastava (Delhi, India)

  • Hemibody dystonia secondary to Neurobehçet disease : a case report

    S. Saaf, Z. El Yacoubi, S. Lhassani, Y. Mimouni, M. Hakimi, M. El Azhari, A. Hazim, J. Aasfara, H. Ouhabi (casablanca, Morocco)

  • Hemichorea syndrome secondary to diabetic striatopathy with contralateral drug-induced parkinsonism: a different threshold for drug induced movement disorders?

    C. Santoro, S. Landolfo, V. Velucci, G. Iliceto (Bari, Italy)

  • Hemidystonia of cerebellar origin

    L. Costa, J. Pinto, C. Machado, I. Amorim (Viana do Castelo, Portugal)

  • Hemifacial Spasm: Recent experience in a movement disorders reference center in Chile

    P. Salles, X. Pizarro, P. Chana, E. Betancur, I. Sanchez (Santiago, Chile)

  • Hemiparkinsonism secondary to a cerebral cavernous malformation (CCM)

    M. González Sánchez, B. De-La-Casa Fages, JR. Pérez Sánchez, A. Contreras Chicote, S. Secades García, E. Luque Buzo, Y. Fernández Bullido, G. Lafuente Gómez, O. Mateo Sierra, FJ. Grandas Pérez (Madrid, Spain)

  • Hereditary generalised dystonia associated with a new large duplication on the X chromosome

    A. Costa, D. Pereira, M. Malaquias, A. Brandão, J. Oliveira, M. Magalhães (Porto, Portugal)

  • Hereditary spastic paraparesis due to SPG11 gene mutation presenting as dopa responsive dystonia

    P. Chatterpal, F. Mustafa, D. Mr, AK. Srivastava, K. Sai Krishna (NEW DELHI, India)

  • Hereditary spastic paraplegia type 4 (SPG4): an international multicenter clinical and genetic study

    A. Orlacchio, E. Panza, R. Rumore, C. Montecchiani, F. Gaudiello, M. Stasi, A. Stigliano, M. Miele, R. Massa, M. Bassi, A. Tessa, F. Santorelli, A. Meyyazhagan, P. St George-Hyslop, J. Pedroso, O. Barsottini, H. Teive, R. Miyamoto, T. Kawarai (Rome, Italy)

  • Hesperidin ameliorates rotenone-induced Parkinson’s disease in mice via improving neuroinflammation and oxidative stress

    D. Singh (Prayagraj, India)

  • Heterozygous aprataxin gene mutation associated with atypical multiple system atrophy phenotype: a case report

    A. Imarisio, A. Pilotto, A. Lupini, G. Biasiotto, I. Zanella, I. Palmieri, EM. Valente, A. Padovani (Pavia, Italy)

  • High Intensity Interval Training for people with Parkinson’s disease: individual response patterns of (non-)motor symptoms and blood-based biomarkers – a crossover single-case experimental design

    E. van Wegen, E. Amaral-Gomez, M. Rietberg, V. de Groot, M. Hirsch, T. Vanbellingen, W. Vanden Berg, O. Vanden Heuvel, C. Vriend (Amsterdam, Netherlands)

  • Holmes Tremor and Dystonia as Manifestation of Benedikt Syndrome in HIV-Related Cerebral Toxoplasmosis : A Case Report

    NER. Raisa, AC. Pratiwi, SB. Rianawati, BDM. Munir (Malang, Indonesia)

  • Home-based titration with Duodenal infusion of Levodopa in People with Parkinson’s disease: an observational feasibility study

    B. Biering-Sørensen, N. Nielsen, A. Isenberg, L. Olsen, M. Javidi, J. Vilhelmsen, M. Møller, M. Olsen, J. Clausen, T. Thomsen (Glostrup, Denmark)

  • Honey prevented MPTP-induced oxidative stress, neuroinflammation and gliosis in adult male Swiss mice.

    F. Sulaimon, R. Ibiyeye, A. Imam, A. Imam, M. Ajao (Ilorin, Nigeria)

  • Hospital based motor cognitive rehabilitation training. what after? An intervention aimed at patients support between admissions

    C. Siri, A. Carollo, G. Manoni, M. Canesi (Milano, Italy)

  • How COVID-19 Impacted Patients with Wilson’s disease? A Questionnaire-based Study From An Indian Movement Disorder Clinic

    A K. Shrivastava, A. Aliyar, MR. Divya, F. Mustafa, K. Sai Krishna, R. Rajan, K. Soman Pillai ()

  • How do people with Parkinson’s disease experience self-optimization of treatment using digitally supported symptom monitoring?

    K. Fåglum, A. Hjorth, M. Christani, P. Hagell, A. Ozanne, F. Bergquist (Varberg, Sweden)

  • How do recently diagnosed individuals with Parkinson’s self-monitor their Parkinson’s symptoms between consultations?

    J. Domingos, J. Dean, C. Godinho, J. Belo, S. Gow, D. Falconer (Nijmegen, Netherlands)

  • How does a diagnosis of Dementia with Parkinson’s influence future care provision?

    B. Mohamed, A. Rafeeq, J. Adenwalla, C. Thomas, S. Page, R. Lewis-Morton, T. Williams, S. Mahon (cardiff, United Kingdom)

  • How helpful is the Swallow tail sign in Parkinson’s disease?

    M. Abu Al-Melh, N. Abdelall, T. Al-Otaibi (Ahmadi, Kuwait)

  • How to dose extended-release carbidopa-levodopa capsules (IPX203) in Parkinson’s disease patients: Experience from the Phase 3 clinical trial

    R. Hauser, G. Banisadr, S. Fisher, H. Visser, R. D'Souza (Tampa, USA)

  • Human cerebellum contributes to the motor frequency coding for essential tremor and volitional rhythmic movements

    YM. Wang, A. Kumar, SH. Kuo, MK. Pan (Yun-Lin county, Taiwan)

  • Huntington disease-like: an atypical presentation of Niemann-Pick type C.

    MB. Charra Castellani, V. Kurtz, E. Knorre, D. Ballesteros (Buenos Aires, Argentina)

  • Huntington’s disease in Senegal Epidemiological and clinical aspects

    M. Fall (Dakar, Senegal)

  • Huntington’s disease-like 2 phenotypes: a case series from a Brazilian referral center

    C. Candeias, G. Santos, M. Costa, A. Pessoa Neto, F. Sarmento, B. Veiga, R. Saba, V. Tumas, S. Silva, V. Borges, H. Ferraz (Sao Paulo, Brazil)

  • Huntington’s disease patients with intermediate allele in Tunisia

    H. Nehdi, Z. Saied, F. Nabli, S. Ben Sassi, R. Amouri (Tunis, Tunisia)

  • Huntingtonism and bilateral basal ganglia hypointensity in a male with an XK variant but no McLeod red cell phenotype

    J. Yu, R. Walker, A. Danek, C. Westhoff, S. Vege, I. Itin (Cleveland, USA)

  • Hydrocephalus associated with Chiari-I malformation presenting with parkinsonism and dystonia

    A. Maheshwary, L. Wolansky, B. Rodrigues, K. Bulsara, D. Karimeddini, B. Springate, N. Prakash (Hartford, USA)

  • Hyperkinetic dystonia in dyskinetic cerebral palsy responds to combined DBS stimulation in thalamus and pallidum.

    A. Zakharova, J. Maclean, T. Sanger (Orange, USA)

  • Hypnosis as an adjunctive treatment for FND, a case series

    J. Chen, J. Waugh, K. Brewer-Mixon, S. Chitnis, D. Morris (Dallas, USA)

  • Hypnosis for Deep Brain Stimulator Surgery

    I. Cohen, D. Englert, M. Henegar, J. Rayner, K. Gamble, S. Patel (Charlotte, USA)

  • Hypothalamic involvement in Multiple System Atrophy: a clinical and neuroimaging study

    J. Pasquini, M. Firbank, L. Best, V. Foster, R. Ceravolo, G. Petrides, K. Anderson, D. Brooks, N. Pavese (Pisa, Italy)

  • Hypoxia‑induced astrocyte activation and its protective effect on Parkinson’s disease

    M. Kim, S-H. Kim, HN. Choi, JY. Je, SP. Yun (Jinju, Republic of Korea)

  • Hypoxic brain injury: a rare cause of chorea and dystonia

    S. Casanova, M. Rocha, A. Rocha, M. Magalhães, H. Costa (Vila Nova Gaia, Portugal)

Jump to:  View All • a b c d e f g [h] i j k l m n o p q r s t u v w x y z

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Welcome to the MDS Abstracts Site
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley